Quotient Sciences

Quotient Sciences, established in 2007, is a prominent entity within the Pharmaceuticals and Biotechnology sectors. The company specializes in the comprehensive development and manufacturing of pharmaceutical products and offers a broad spectrum of services. Its core offerings encompass drug development, clinical and commercial manufacturing, and advanced pharmaceutical development services. Quotient Sciences leverages scientific expertise to deliver innovative solutions across the drug lifecycle, supporting clients from early-stage research through to commercialization.

Operating with a substantial workforce of 1,000 to 5,000 employees across 8 locations, Quotient Sciences demonstrates significant operational scale. The company's expertise extends to formulation development, clinical testing, and scientific simulation and modeling. For insights into their organizational structure and leadership, one can explore Meet Quotient Sciences' team. Their services cater to niche areas such as oncology and rare diseases, utilizing advanced capabilities like HPAPI handling and end-to-end service delivery.

With an annual revenue of $394.4M, Quotient Sciences positions itself competitively against industry players like Ergomed, ALMAC, and IQVIA Biotech. The company's product portfolio includes critical components like drug substances and advanced formulations, supporting the delivery of medicines to patients. Their commitment to quality is evident in services like GMP manufacturing and validation. Hashtags suggest a global presence, including operations in the UK and Europe, and a focus on employee benefits and specialized roles within the scientific and operational domains.